4512.T Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 09:15):

Stats
Šios dienos apimtis	27 000.00
Vidutinė apimtis	152 720
Rinkos kapitalizacija	7.95B
EPS	¥0 ( 2024-02-05 )
Kita pelno data	( ¥0 ) 2024-05-12
Last Dividend	¥3.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	-44.64
ATR14	¥0.371 (0.16%)

Tūris Koreliacija

Ilgas: 0.14 (neutral)

Trumpas: -0.39 (neutral)

Signal:(39.173) Neutral

Wakamoto Pharmaceutical Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Wakamoto Pharmaceutical Koreliacija - Valiuta/Žaliavos

0.02
( neutral )

0.04
( neutral )

0.03
( neutral )

-0.05
( neutral )

-0.08
( neutral )

-0.18
( neutral )

Wakamoto Pharmaceutical Finansinės ataskaitos

Annual	2022
Pajamos:	¥8.66B
Bruto pelnas:	¥4.11B (47.44 %)
EPS:	¥3.98

FY	2022
Pajamos:	¥8.66B
Bruto pelnas:	¥4.11B (47.44 %)
EPS:	¥3.98

FY	2022
Pajamos:	¥8.38B
Bruto pelnas:	¥4.36B (51.96 %)
EPS:	¥6.87

FY	2021
Pajamos:	¥8.89B
Bruto pelnas:	¥4.49B (50.45 %)
EPS:	¥-17.34

Financial Reports:

No articles found.

Wakamoto Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥0 (N/A)	¥3.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Wakamoto Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 5.84 - average (61.59%) | Divividend Growth Potential Score: 1.350 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥2.50	2001-03-27
Last Dividend	¥3.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	17	--
Total Paid Out	¥45.50	--
Avg. Dividend % Per Year	0.00%	--
Score	1.45	--
Div. Sustainability Score	5.84
Div.Growth Potential Score	1.350
Div. Directional Score	3.59	--

Next Divdend (Est)
(2025-02-24)

¥0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.45

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8016.T	Ex Dividend Junior	2024-02-28	Annually	0.00%
7267.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6498.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
5713.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4530.T	Ex Dividend Knight	2024-02-28	Semi-Annually	0.00%
3688.T	Ex Dividend Junior	2023-12-28	Semi-Annually	0.00%
3001.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
1861.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
9856.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8914.T	Ex Dividend Junior	2023-12-28	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0223	1.500	-0.445	-0.668	[0 - 0.5]
returnOnAssetsTTM	-0.0116	1.200	-0.388	-0.466	[0 - 0.3]
returnOnEquityTTM	-0.0149	1.500	-1.277	-1.915	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	4.52	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	3.24	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.860	1.500	0.780	1.171	[0.2 - 2]
debtRatioTTM	0.00656	-1.500	9.89	-10.00	[0 - 0.6]
interestCoverageTTM	-264.52	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	23.64	2.00	2.12	4.24	[0 - 30]
freeCashFlowPerShareTTM	23.64	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.00855	-1.500	9.97	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.470	1.000	5.50	5.50	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0190	1.000	-2.38	-2.38	[0.1 - 0.6]
cashFlowToDebtRatioTTM	8.21	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.523	0.800	9.85	7.88	[0.5 - 2]
Total Score				5.84

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-44.93	1.000	-4.64	0	[1 - 100]
returnOnEquityTTM	-0.0149	2.50	-0.821	-1.915	[0.1 - 1.5]
freeCashFlowPerShareTTM	23.64	2.00	2.12	10.00	[0 - 30]
dividendYielPercentageTTM	1.304	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	23.64	2.00	2.12	4.24	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.322	1.500	-5.48	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.103	1.000	9.93	0	[0.1 - 0.5]
Total Score				1.350

Wakamoto Pharmaceutical

Wakamoto Pharmaceutical Co., Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong Wakamoto, a gastrointestinal drug for digestion, intestinal regulation, and nutritional supplementation. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943. Wakamoto Pharmaceutical Co., Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.